| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
RALEIGH, N. C., November 10, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the third quarter ended September 30, 2026. |
| 12 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
RALEIGH, N. C., August 12, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated its full year 2026 outlook. |
| 30 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
AMENDMENT NO. 7, dated as of June 30, 2026 (this “Amendment”), by and among LUMEXA IMAGING, INC., a Delaware corporation (the “LII Borrower”), LUMEXA IMAGING OUTPATIENT, INC., a Delaware corporation (the “LIO Borrower” and together with ... |
| 12 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On June 10, 2026, Lumexa Imaging Holdings, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on: (i) the election of three Class I directors ... |
| 12 May 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
RALEIGH, NORTH CAROLINA, May 12, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 ... |
| 09 Apr 2026 |
8-K: Regulation FD Disclosure
On April 8, 2026, Lumexa Imaging Holdings, Inc. (the “Company”) held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance. |
| 26 Mar 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
RALEIGH, NORTH CAROLINA, March 26, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and re... |
| 02 Mar 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date |
| 15 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Thank you for notifying me that you have decided to resign from your role. As we have discussed, your employment with Lumexa Imaging Holdings, Inc. and its affiliates (collectively, the “Company”) will end effective March 13, 2026 (the “... |
| 18 Dec 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
AMENDMENT NO. 5, dated as of December 17, 2025 (this “Amendment”), by and among LUMEXA IMAGING, INC., a Delaware corporation (the “LII Borrower”), LUMEXA IMAGING OUTPATIENT, INC., a Delaware corporation (the “LIO Borrower” and together w... |
| 12 Dec 2025 |
8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +2 more
Lumexa Imaging Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representati... |
Loading...